CollPlant Biotechnologies (CLGN) Financial Statements & Analysis

CollPlant Biotechnologies (CLGN) Income Statement

CollPlant Biotechnologies reported revenue of $2.37M in fiscal 2025 (fiscal year ended Dec 31, 2025), up 360.4% from $515.00K a year earlier. Net income was $11.49M, down 30.8% year over year, a net margin of 484.6%. Gross margin was 64.8% and operating margin 484.3%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $108.00K, down 39.7% from the same quarter a year earlier.

CollPlant Biotechnologies Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

CollPlant Biotechnologies Ltd. income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Mar 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Mar 2020	Mar 2019	Dec 2017
Revenue & Gross Profit
Revenue	2.37	0.52	10.96	10.96	0.30	15.64	6.14	2.32	4.79	0.48
Cost of Revenue	0.84	1.63	3.09	1.99	1.48	2.01	3.00	1.88	1.90	0.31
Gross Profit	1.54	-1.11	7.87	8.97	-1.18	13.64	3.14	0.44	3.11	0.16
Operating Expenses
Research & Development	8.19	10.52	10.48	10.48	10.26	7.63	4.07	4.41	5.16	4.05
Selling, General & Administrative	4.83	5.63	4.89	6.00	5.67	5.94	4.67	3.66	3.70	2.30
Operating Expenses	13.02	16.14	15.38	16.48	15.92	13.57	8.73	8.07	7.68	6.72
Operating Income	11.48	17.25	-7.51	-7.51	-17.10	0.07	-5.60	-7.63	-	-
Other Income/Expense
Interest Income	0.38	0.74	0.79	0.79	0.32	0.22	0.00	0.00	0.00	0.00
Interest Expense	0.02	0.02	0.01	-	0.03	0.04	-0.02	0.07	0.03	0.11
Other Income/Expense	-0.01	0.64	0.49	-0.29	0.17	-0.01	0.03	-3.53	-2.00	-0.09
Income
Income Before Tax	-11.49	-16.61	-7.02	-7.02	-16.93	0.24	-5.77	-11.16	-	-
Income Tax Expense	0.00	0.00	0.00	-	0.00	0.00	0.00	0.00	2.96	0.03
Net Income	11.49	16.61	-7.02	-7.02	-16.93	0.24	-5.77	-11.16	-6.25	-5.80
Net Income - Continuous Operations	-11.49	-16.61	-7.02	-7.02	-16.93	0.24	-5.77	-11.16	-6.25	-5.80
Net Income - Discontinued Operations	-	-	-	-	-	-	-	-	-	-
EBITDA	-10.57	-16.21	-5.91	-6.41	-15.82	0.84	-4.94	-10.55	-5.88	-5.41
EBIT	-11.48	-17.25	-	-7.51	-17.10	0.07	-5.60	-	-	-
Depreciation & Amortization	0.91	1.04	1.10	1.10	1.08	0.77	0.66	0.54	0.34	0.29
Earnings Per Share
Basic EPS	-9.00	-15.00	-6.00	-1.00	-15.00	-	-1.00	-29.00	-14.00	-23.00
Diluted EPS	-1.00	-1.00	-6.00	-1.00	-15.00	-	-1.00	-29.00	-14.00	-23.00
Basic Shares Outstanding	1.22	1.15	1.14	11.39	1.10	9.97	6.89	0.50	0.44	0.27
Diluted Shares Outstanding	1.22	1.15	1.14	11.39	1.10	11.97	6.89	0.50	0.44	0.27

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About CollPlant Biotechnologies Financial Statements

What was CollPlant Biotechnologies's revenue in fiscal 2025?

CollPlant Biotechnologies reported revenue of $2.37M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was up 360.4% from $515.00K a year earlier.

Is CollPlant Biotechnologies profitable?

Yes. CollPlant Biotechnologies earned net income of $11.49M in fiscal 2025, a net margin of 484.6%. In fiscal 2024 it earned $16.61M.

What is CollPlant Biotechnologies's operating margin?

CollPlant Biotechnologies's operating income was $11.48M on revenue of $2.37M in fiscal 2025, an operating margin of 484.3%, compared with 3349.7% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition